Introduction
Emigration of neutrophils from the circulating blood to the site of the injury is a cardinal event during the inflammatory process. This phenomenon is complex and mediated by various molecules acting in different ways. Interleukin 1 and 8 (IL-1, IL-8), tumour necrosis factor (TNF), and the complement fragments and leukotriene B4 (LTB4) are macrophage products thought to be involved in the migration of neutrophils to the inflamed site, a phenomenon characteristic of the acute phase of the inflammatory process. [2] [3] [4] [5] Some products such as C5a and LTB 4 may have a direct chemotactic effect on neutrophils. [6] [7] [8] Others may act (Fig. 1A) . The dose-response curve obtained for the in vitro chemotactic activity of purified MNCF was bell-shaped (Fig. 1B) . The chemotactic activity was shown to result from haptotaxis rather than chemokinesis since the neutrophil chemokinetic migration induced by purified MNCF was similar to that of a negative control. While in vitro neutrophil migration was observed with a positive haptotactic gradient with MNCF, the negative haptotactic gradient of MNCF was unable to induce neutrophil migration (Fig. 2 ).
These data indicate that the neutrophil migration induced by filter-bound MNCF was gradientdriven. (Fig. 1) , this treatment did not affect the neutrophil migration induced by the heparin-not-bound fraction. In the in vitro assay, the chemotactic activity of the heparin-bound fraction was inhibited by preincubation with anti-IL-8 serum. A similar result was observed with rhlL-8. On the other hand, the in vitro chemotactic activity of the heparin-notbound fraction was not affected by the same amount of anti-IL-8 serum.
Relationship between migration-inducing and carbohydrate-binding activities: Fig. 3A shows that 0.4M D-galactose did not affect the chemotactic activity of FMLP or IL-8 in vitro, but did inhibit the activity of purified MNCF by more than 90%. As expected, the chemotactic activity of crude MNCF was only partially reduced (28%) by the same concentration of D-galactose. At the same concentration, a non-specific sugar ()-mannose) had no effect on the chemotactic activities of FMLP or purified MNCF (Fig. 3B ).
The incubation of crude or purified MNCF with D-galactose (0.4 M) also inhibited the ability to induce neutrophil migration into the air pouch MNCF, a lectin-like ytokine of dexamethasone-pretreated rats by 40 and 46%, respectively. At the same concentration, a nonspecific sugar (>mannose) had no effect on the in vivo or in vitro chemotactic activity of crude or purified MNCF (Table 2 ).
Discussion
In a companion paper, 21 we have described the purification to homogeneity of a .54kDa acidic protein extracted from the supernatant of LPS-stimulated macrophage monolayers. Like the crude macrophage-derived neutrophil chemotactic factor (MNCF), this protein was able to stimulate neutrophil migration in animals pretreated 14 21 with dexamethasone. This in vivo chemotactic activity is an uncommon cytokine characteristic and seems peculiar to MNCF. MNCF behaves like a lectin on the basis of its ability to bind to immobilized )-galactose and the inhibition of its biological activity by the same sugar. 22 In line with our previous observations for crude MNCF 
